Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Surgical Endoscopy
Erschienen in: Surgical Endoscopy 4/2017

13.09.2016

Diabetes improvement and resolution following laparoscopic vertical sleeve gastrectomy (LVSG) versus laparoscopic Roux-en-Y gastric bypass (LRYGB) procedures: a systematic review of randomized controlled trials

Erschienen in: Surgical Endoscopy | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

The prevalence of type 2 diabetes is growing in both developed and developing countries and is strongly linked with the prevalence of obesity. Bariatric surgical procedures such as laparoscopic vertical sleeve gastrectomy (LVSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB) are increasingly being utilized to manage related comorbid chronic conditions, including type 2 diabetes.

Methods

A systematic review of randomized controlled trials (RCTs) was undertaken using the PRISMA guidelines to investigate the postoperative impact on diabetes resolution following LVSG versus LRYGB.

Results

Seven RCTs involving a total of 732 patients (LVSG n = 365, LRYGB n = 367) met inclusion criteria. Significant diabetes resolution or improvement was reported with both procedures across all time points. Similarly, measures of glycemic control (HbA1C and fasting blood glucose levels) improved with both procedures, with earlier improvements noted in LRYGB that stabilized and did not differ from LVSG at 12 months postoperatively. Early improvements in measures of insulin resistance in both procedures were also noted in the studies that investigated this.

Conclusions

This systematic review of RCTs suggests that both LVSG and LRYGB are effective in resolving or improving preoperative type 2 diabetes in obese patients during the reported 3- to 5-year follow-up periods. However, further studies are required before longer-term outcomes can be elucidated. Areas identified that need to be addressed for future studies on this topic include longer follow-up periods, standardized definitions and time point for reporting, and financial analysis of outcomes obtained between surgical procedures to better inform procedure selection.
Literatur
1.
Preventative Health Taskforce (2009) Australia: the healthiest country by 2020. In: Obesity Working Group ed. Technical report 1: Obesity in Australia an need for urgent action, including addendum for October 2008 to June 2009. Australian Government, Canberra
2.
Sassi F, Devaux M, Checchini M, Rusticelli E (2009) The obesity epidemic: analysis of past and projected future trends in selected OECD countries. In: OECD Health working papers no 45. OECD, Paris
3.
Colagiuri S, Lee CM, Colagiuri R, Magliano D, Shaw JE, Zimmet PZ, Caterson ID (2010) The cost of overweight and obesity in Australia. Med J Aust 192:260–264PubMed
4.
Kanavos P, van den Aardweg S, Schurer W (2012) Diabetes expenditure, burden of disease and management in 5 EU countries. In: LSE Health, London School of Economics, 113
5.
6.
Colquitt JL, Pickett K, Loveman E, Frampton GK (2014) Surgery for weight loss in adults. Cochrane Database Syst Rev 8:CD003641
7.
8.
Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, Clegg AJ (2009) The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess 13:1–190, 215–357, iii–iv
9.
Borisenko O, Adam D, Funch-Jensen P, Ahmed AR, Zhang R, Colpan Z, Hedenbro J (2015) Bariatric surgery can lead to net cost savings to health care systems: results from a comprehensive European decision analytic model. Obes Surg 25:1559–1568CrossRefPubMedPubMedCentral
10.
Suter M, Donadini A, Romy S, Demartines N, Giusti V (2011) Laparoscopic Roux-en-Y gastric bypass: significant long-term weight loss, improvement of obesity-related comorbidities and quality of life. Ann Surg 254:267–273CrossRefPubMed
11.
Miras AD, le Roux CW (2013) Mechanisms underlying weight loss after bariatric surgery. Nat Rev Gastroenterol Hepatol 10:575–584CrossRefPubMed
12.
Osland E, Yunus RM, Khan S, Memon B, Memon MA (2016) Late postoperative complications in laparoscopic sleeve gastrectomy (LVSG) versus laparoscopic Roux-en-y gastric bypass (LRYGB): meta-analysis and systematic review. Surg Laparosc Endosc Percutaneous Tech 26:193–201CrossRef
13.
Osland E, Yunus RM, Khan S, Alodat T, Memon B, Memon MA (2016) Postoperative early major and minor complications in laparoscopic vertical sleeve gastrectomy (LVSG) versus laparoscopic Roux-en-Y gastric bypass (LRYGB) procedures: a meta-analysis and systematic review. Obes Surg 26:2273–2284. doi:10.​1007/​s11695-016-2101-8 CrossRefPubMed
14.
Regan JP, Inabnet WB, Gagner M, Pomp A (2003) Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg 13:861–864CrossRefPubMed
15.
Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Br Med J 339:b2535CrossRef
16.
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12CrossRefPubMed
17.
Biter LU, Gadiot RP, Grotenhuis BA, Dunkelgrun M, van Mil SR, Zengerink HJ, Smulders JF, Mannaerts GH (2015) The Sleeve Bypass Trial: a multicentre randomized controlled trial comparing the long term outcome of laparoscopic sleeve gastrectomy and gastric bypass for morbid obesity in terms of excess BMI loss percentage and quality of life. BMC Obes 2:30CrossRefPubMedPubMedCentral
18.
Fischer L, Wekerle AL, Bruckner T, Wegener I, Diener MK, Frankenberg MV, Gartner D, Schon MR, Raggi MC, Tanay E, Brydniak R, Runkel N, Attenberger C, Son MS, Turler A, Weiner R, Buchler MW, Muller-Stich BP (2015) BariSurg trial: sleeve gastrectomy versus Roux-en-Y gastric bypass in obese patients with BMI 35–60 kg/m2—a multi-centre randomized patient and observer blind non-inferiority trial. BMC Surg 15:87CrossRefPubMedPubMedCentral
19.
Yang J, Wang C, Cao G, Yang W, Yu S, Zhai H, Pan Y (2015) Long-term effects of laparoscopic sleeve gastrectomy versus roux-en-Y gastric bypass for the treatment of Chinese type 2 diabetes mellitus patients with body mass index 28-35 kg/m2. BMC Surg 15:88CrossRefPubMedPubMedCentral
20.
Zhang Y, Zhao H, Cao Z, Sun X, Zhang C, Cai W, Liu R, Hu S, Qin M (2014) A randomized clinical trial of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy for the treatment of morbid obesity in China: a 5-year outcome. Obes Surg 24:1617–1624CrossRefPubMed
21.
Peterli R, Borbely Y, Kern B, Gass M, Peters T, Thurnheer M, Schultes B, Laederach K, Bueter M, Schiesser M (2013) Early results of the Swiss Multicentre Bypass or Sleeve Study (SM-BOSS): a prospective randomized trial comparing laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. Ann Surg 258:690–694 (discussion 695) CrossRefPubMedPubMedCentral
22.
Helmio M, Victorzon M, Ovaska J, Leivonen M, Juuti A, Peromaa-Haavisto P, Nuutila P, Vahlberg T, Salminen P (2014) Comparison of short-term outcome of laparoscopic sleeve gastrectomy and gastric bypass in the treatment of morbid obesity: a prospective randomized controlled multicenter SLEEVEPASS study with 6-month follow up. SJS 103:175–181PubMed
23.
Kehagias I, Karamanakos SN, Argentou M, Kalfarentzos F (2011) Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the management of patients with BMI <50 kg/m2. Obes Surg 21:1650–1656CrossRefPubMed
24.
de Barros F, Setubal S, Martinho JM, Monteiro AB (2015) Early endocrine and metabolic changes after bariatric surgery in grade III morbidly obese patients: a randomized clinical trial comparing sleeve gastrectomy and gastric bypass. Metab Syndr Relat Disord 13:264–271CrossRefPubMed
25.
Keidar A, Heschkop KJ, Marko L, Schweiger C, Hecht L, Bartov N, Kedar A, Weiss R (2013) Roux-en-Y gastric bypass vs sleeve gastrectomy for obese patients with type 2 diabetes: a randomised trial. Diabetalogica 56:1914–1918CrossRef
26.
Peterli R, Wolnerhanssen B, Peters T, Devaux N, Kern B, Christoffel-Courtin C, Drewe J, von Flue M, Beglinger C (2009) Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg 250:234–241CrossRefPubMed
27.
Peterli R. Personal communication regarding diabetes resolution/improvement from SM-BOSS paper (Ann Surg 2013). Via email communication with E Osland 16 June 2016
28.
Wang MC, Guo XH, Zhang YW, Zhang YL, Zhang HH, Zhang YC (2015) Laparoscopic Roux-en-Y gastric bypass versus sleeve gastrectomy for obese patients with Type 2 diabetes: a meta-analysis of randomized controlled trials. Am Surg 81:166–171PubMed
29.
Cho JM, Kim HJ, Lo Menzo E, Park S, Szomstein S, Rosenthal RJ (2015) Effect of sleeve gastrectomy on type 2 diabetes as an alternative treatment modality to Roux-en-Y gastric bypass: systemic review and meta-analysis. Surg Obes Relat Dis 11:1273–1280CrossRefPubMed
30.
Li JF, Lai DD, Lin ZH, Jiang TY, Zhang AM, Dai JF (2014) Comparison of the long-term results of Roux-en-Y gastric bypass and sleeve gastrectomy for morbid obesity: a systematic review and meta-analysis of randomized and nonrandomized trials. Surg Laparosc Endosc Percutaneous Tech 24:1–11CrossRef
31.
Yip S, Plank LD, Murphy R (2013) Gastric bypass and sleeve gastrectomy for type 2 diabetes: a systematic review and meta-analysis of outcomes. Obes Surg 23:1994–2003CrossRefPubMed
32.
Zhang C, Yuan Y, Qiu C, Zhang W (2014) A meta-analysis of 2-year effect after surgery: laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for morbid obesity and diabetes mellitus. Obes Surg 24:1528–1535CrossRefPubMed
33.
Zhang Y, Wang J, Sun X, Cao Z, Xu X, Liu D, Xin X, Qin M (2015) Laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass for morbid obesity and related comorbidities: a meta-analysis of 21 studies. Obes Surg 25:19–26CrossRefPubMed
34.
Li J, Lai D, Wu D (2016) Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy to treat morbid obesity-related comorbidities: a systematic review and meta-analysis. Obes Surg 26:429–442CrossRefPubMed
35.
Padwal R, Klarenbach S, Wiebe N, Hazel M, Birch D, Karmali S, Sharma AM, Manns B, Tonelli M (2011) Bariatric surgery: a systematic review of the clinical and economic evidence. J Gen Intern Med 26:1183–1194CrossRefPubMedPubMedCentral
36.
Major P, Matlok M, Pedziwiatr M, Migaczewski M, Budzynski P, Stanek M, Kisielewski M, Natkaniec M, Budzynski A (2015) Quality of life after bariatric surgery. Obes Surg 25:1703–1710CrossRefPubMedPubMedCentral
37.
Nadalini L, Zenti MG, Masotto L, Indelicato L, Fainelli G, Bonora F, Battistoni M, Romani B, Genna M, Zoppini G, Bonora E (2014) Improved quality of life after bariatric surgery in morbidly obese patients. Interdisciplinary group of bariatric surgery of Verona (G.I.C.O.V.). Il Giornale di chirurgia 35:161–164PubMedPubMedCentral
38.
Campos GM, Rabl C, Roll GR, Peeva S, Prado K, Smith J, Vittinghoff E (2011) Better weight loss, resolution of diabetes, and quality of life for laparoscopic gastric bypass vs banding: results of a 2-cohort pair-matched study. Arch Surg 146:149–155CrossRefPubMed
39.
Laurino Neto RM, Herbella FA (2013) Changes in quality of life after short and long term follow up of Roux-en-Y gastric bypass for morbid obesity. Arq Gastroenterol 50:186–190CrossRefPubMed
40.
Julia C, Ciangura C, Capuron L, Bouillot JL, Basdevant A, Poitou C, Oppert JM (2013) Quality of life after Roux-en-Y gastric bypass and changes in body mass index and obesity-related comorbidities. Diabetes Metab 39:148–154CrossRefPubMed
41.
Bennett JC, Wang H, Schirmer BD, Northup CJ (2007) Quality of life and resolution of co-morbidities in super-obese patients remaining morbidly obese after Roux-en-Y gastric bypass. Surg Obes Relat Dis 3:387–391CrossRefPubMed
42.
Oh SH, Song HJ, Kwon JW, Park DJ, Lee YJ, Chun H, Kim S, Shim KW (2013) The improvement of quality of life in patients treated with bariatric surgery in Korea. J Korean Surg Soc 84:131–139CrossRefPubMedPubMedCentral
43.
O’Brien PE, Dixon JB, Laurie C, Skinner S, Proietto J, McNeil J, Strauss B, Marks S, Schachter L, Chapman L, Anderson M (2006) Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med 144:625–633CrossRefPubMed
44.
Karlsen TI, Lund RS, Roislien J, Tonstad S, Natvig GK, Sandbu R, Hjelmesaeth J (2013) Health related quality of life after gastric bypass or intensive lifestyle intervention: a controlled clinical study. Health Qual Life Outcomes 11:17CrossRefPubMedPubMedCentral
45.
Knop FK, Taylor R (2013) Mechanism of metabolic advantages after bariatric surgery: it’s all gastrointestinal factors versus it’s all food restriction. Diabetes Care 36(Suppl 2):S287–S291CrossRefPubMedPubMedCentral
46.
Nannipieri M, Baldi S, Mari A, Colligiani D, Guarino D, Camastra S, Barsotti E, Berta R, Moriconi D, Bellini R, Anselmino M, Ferrannini E (2013) Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones. J Clin Endocrinol Metab 98:4391–4399CrossRefPubMed
47.
Ioconelli A, Gaggini M, Gastaldelli A, Mingrone G (2012) Short term effects of laparoscopic adjustable gastric banding (LAGB) and Roux-en-Y gastric bypass (RYGB) vs very low calorie diet (VLCD). Diabetologia 55(supp 1):584
48.
Bojsen-Moller KN, Dirksen C, Jorgensen NB, Jacobsen SH, Serup AK, Albers PH, Hansen DL, Worm D, Naver L, Kristiansen VB, Wojtaszewski JF, Kiens B, Holst JJ, Richter EA, Madsbad S (2014) Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass. Diabetes 63:1725–1737CrossRefPubMed
49.
Metadaten
Titel
Diabetes improvement and resolution following laparoscopic vertical sleeve gastrectomy (LVSG) versus laparoscopic Roux-en-Y gastric bypass (LRYGB) procedures: a systematic review of randomized controlled trials
Publikationsdatum
13.09.2016
Erschienen in
Surgical Endoscopy / Ausgabe 4/2017
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-016-5202-5

Weitere Artikel der Ausgabe 4/2017

Surgical Endoscopy 4/2017 Zur Ausgabe

OriginalPaper

Transaxillary robotic modified radical neck dissection: a 5-year assessment of operative and oncologic outcomes

OriginalPaper

Current trends in the practice of endoscopy among surgeons in the USA

OriginalPaper

Robotic partial nephrectomy performed with Airseal versus a standard CO2 pressure pneumoperitoneum insufflator: a prospective comparative study

OriginalPaper

What is the value of the SAGES/AORN MIS checklist? A multi-institutional practical assessment

OriginalPaper

Technical description of the microinjection pump (MIP®) and granulometric characterization of the aerosol applied for pressurized intraperitoneal aerosol chemotherapy (PIPAC)

OriginalPaper

Prevertebral cervical approach: a pure endoscopic surgical technique for posterior mediastinum parathyroid adenomas

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.